FDA Drug Application (021490) for FEMCON FE by APIL

Back to FDA Applications sponsored by APIL

Application Number021490
Product Number001
FormTABLET, CHEWABLE;ORAL
Dosage0.035MG;0.4MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameFEMCON FE
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORETHINDRONE82


Back to FDA Applications sponsored by APIL